drugset / Trial / NCT03836703

Doubling the Iron Dose to Prevent IDA in Twin Pregnant Women

NCT03836703 ↗

Phase 4 Completed 450 enrolled Ain Shams University
RandomizedParallel-groupSingle-blindPrevention

Summary

In twin pregnancies, the maternal iron demands are magnified, estimated at 1.8 times more than in singleton pregnancies due to greater maternal red blood cell mass and plasma volume expansion as well as increased fetal and placental requirements. With a lack of randomized controlled trials assessing the adequacy of iron supplements on twin pregnancy, various recommendations are based on level 3 clinical expert opinions at most.

Timeline

Start
2019-02-01
Primary completion
2020-07-01
Completion
2020-08-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Feroglobin Unknown 106 mg Oral

Indications